Myeloid-derived suppressor cells impair alveolar macrophages through PD-1 receptor ligation during Pneumocystis pneumonia

Infection and Immunity

Volumn 83, Issue 2, 2015, Pages 572-582

  Lei, Guang Sheng ^a   Zhang, Chen ^a   Lee, Chao Hung ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H3; PROGRAMMED DEATH 1 RECEPTOR; CD274 PROTEIN, MOUSE; CHEMOKINE RECEPTOR; GR-1 PROTEIN, MOUSE; HISTONE; ONCOPROTEIN; PDCD1 PROTEIN, MOUSE; PROGRAMMED DEATH 1 LIGAND 1; PROTO-ONCOGENE PROTEIN SPI-1; TRANSACTIVATOR PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; CELL STRUCTURE; CONTROLLED STUDY; DNA METHYLATION; FEMALE; GENE EXPRESSION; HISTONE ACETYLATION; HISTONE MODIFICATION; LUNG ALVEOLUS MACROPHAGE; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PHAGOCYTOSIS; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SUPPRESSOR CELL; ACETYLATION; ANIMAL; BIOSYNTHESIS; BONE MARROW CELL; C57BL MOUSE; CYTOLOGY; DOWN REGULATION; GENETICS; IMMUNOLOGY; LUNG; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PNEUMOCYSTIS JIROVECI;

ACETYLATION; ANIMALS; ANTIGENS, CD274; DNA METHYLATION; DOWN-REGULATION; HISTONES; LUNG; MACROPHAGES, ALVEOLAR; MICE; MICE, INBRED C57BL; MYELOID CELLS; PHAGOCYTOSIS; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; PROGRAMMED CELL DEATH 1 RECEPTOR; PROTO-ONCOGENE PROTEINS; RECEPTORS, CHEMOKINE; TRANS-ACTIVATORS;

EID: 84921417519     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.02686-14     Document Type: Article

References (82)

1. Lasbury ME, Lin P, Tschang D, Durant PJ, Lee CH. 2004. Effect of bronchoalveolar lavage fluid from Pneumocystis carinii-infected hosts on phagocytic activity of alveolar macrophages. Infect Immun 72:2140-2147. http://dx.doi.org/10.1128/IAI.72.4.2140-2147.2004.
2. Koziel H, Eichbaum Q, Kruskal BA, Pinkston P, Rogers RA, Armstrong MY, Richards FF, Rose RM, Ezekowitz RA. 1998. Reduced binding and phagocytosis of Pneumocystis carinii by alveolar macrophages from persons infected with HIV-1 correlates with mannose receptor downregulation. J Clin Invest 102:1332-1344. http://dx.doi.org/10.1172/JCI560.
3. Fleury J, Escudier E, Pocholle MJ, Carre C, Bernaudin JF. 1985. Cell population obtained by bronchoalveolar lavage in Pneumocystis carinii pneumonitis. Acta Cytol 29:721-726.
4. Fleury-Feith J, Van Nhieu JT, Picard C, Escudier E, Bernaudin JF. 1989. Bronchoalveolar lavage eosinophilia associated with Pneumocystis carinii pneumonitis in AIDS patients. Comparative study with non-AIDS patients. Chest 95:1198-1201.
5. Young JA, Hopkin JM, Cuthbertson WP. 1984. Pulmonary infiltrates in immunocompromised patients: diagnosis by cytological examination of bronchoalveolar lavage fluid. J Clin Pathol 37:390-397. http://dx.doi.org/10.1136/jcp.37.4.390.
6. Young JA, Stone JW, McGonigle RJ, Adu D, Michael J. 1986. Diagnosing Pneumocystis carinii pneumonia by cytological examination of bronchoalveolar lavage fluid: report of 15 cases. J Clin Pathol 39:945-949. http://dx.doi.org/10.1136/jcp.39.9.945.
7. Sadaghdar H, Huang ZB, Eden E. 1992. Correlation of bronchoalveolar lavage findings to severity of Pneumocystis carinii pneumonia in AIDS. Evidence for the development of high-permeability pulmonary edema. Chest 102:63-69.
8. Lasbury ME, Durant PJ, Bartlett MS, Smith JW, Lee CH. 2003. Correlation of organism burden and alveolar macrophage counts during infection with Pneumocystis carinii and recovery. Clin Diagn Lab Immunol 10:293-302. http://dx.doi.org/10.1128/CDLI.10.2.293-302.2003.
9. Lasbury ME, Merali S, Durant PJ, Tschang D, Ray CA, Lee CH. 2007. Polyamine-mediated apoptosis of alveolar macrophages during Pneumocystis pneumonia. J Biol Chem 282:11009-11020. http://dx.doi.org/10.1074/jbc.M611686200.
10. Liao CP, Lasbury ME, Wang SH, Zhang C, Durant PJ, Murakami Y, Matsufuji S, Lee CH. 2009. Pneumocystis mediates overexpression of antizyme inhibitor resulting in increased polyamine levels and apoptosis in alveolar macrophages. J Biol Chem 284:8174-8184. http://dx.doi.org/10.1074/jbc.M805787200.
11. Zhang C, Wang SH, Liao CP, Shao S, Lasbury ME, Durant PJ, Lee CH. 2010. Downregulation of PU.1 leads to decreased expression of Dectin-1 in alveolar macrophages during Pneumocystis pneumonia. Infect Immun 78:1058-1065. http://dx.doi.org/10.1128/IAI.01141-09.
12. Eichbaum Q, Heney D, Raveh D, Chung M, Davidson M, Epstein J, Ezekowitz RA. 1997. Murine macrophage mannose receptor promoter is regulated by the transcription factors PU.1 and SP1. Blood 90:4135-4143.
13. Moulton KS, Semple K, Wu H, Glass CK. 1994. Cell-specific expression of the macrophage scavenger receptor gene is dependent on PU.1 and a composite AP-1/ets motif. Mol Cell Biol 14:4408-4418.
14. Eichbaum QG, Iyer R, Raveh DP, Mathieu C, Ezekowitz RA. 1994. Restriction of interferon gamma responsiveness and basal expression of the myeloid human Fc gamma R1b gene is mediated by a functional PU.1 site and a transcription initiator consensus. J Exp Med 179:1985-1996. http://dx.doi.org/10.1084/jem.179.6.1985.
15. Panopoulos AD, Bartos D, Zhang L, Watowich SS. 2002. Control of myeloid-specific integrin alpha Mbeta 2 (CD11b/CD18) expression by cytokines is regulated by Stat3-dependent activation of PU.1. J Biol Chem 277:19001-19007. http://dx.doi.org/10.1074/jbc.M112271200.
16. Zhang C, Lei GS, Shao S, Jung HW, Durant PJ, Lee CH. 2012. Accumulation of myeloid-derived suppressor cells in the lungs during Pneumocystis pneumonia. Infect Immun 80:3634-3641. http://dx.doi.org/10.1128/IAI.00668-12.
17. Gabrilovich DI, Nagaraj S. 2009. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 9:162-174. http://dx.doi.org/10.1038/nri2506.
18. Youn JI, Collazo M, Shalova IN, Biswas SK, Gabrilovich DI. 2011. Characterization of the nature of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. J Leukoc Biol 91:167-181. http://dx.doi.org/10.1189/jlb.0311177.
19. Nagaraj S, Gabrilovich DI. 2010. Myeloid-derived suppressor cells in human cancer. Cancer J 16:348-353. http://dx.doi.org/10.1097/PPO.0b013e3181eb3358.
20. Green KA, Cook WJ, Green WR. 2013. Myeloid-derived suppressor cells in murine retrovirus-induced AIDS inhibit T- and B-cell responses in vitro that are used to define the immunodeficiency. J Virol 87:2058-2071. http://dx.doi.org/10.1128/JVI.01547-12.
21. Gantt S, Gervassi A, Jaspan H, Horton H. 2014. The role of myeloidderived suppressor cells in immune ontogeny. Front Immunol 5:387. http://dx.doi.org/10.3389/fimmu.2014.00387.
22. McGrath MM, Najafian N. 2012. The role of coinhibitory signaling pathways in transplantation and tolerance. Front Immunol 3:47. http://dx.doi.org/10.3389/fimmu.2012.00047.
23. Watanabe N, Gavrieli M, Sedy JR, Yang J, Fallarino F, Loftin SK, Hurchla MA, Zimmerman N, Sim J, Zang X, Murphy TL, Russell JH, Allison JP, Murphy KM. 2003. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol 4:670-679. http://dx.doi.org/10.1038/ni944.
24. Watanabe N, Nakajima H. 2012. Coinhibitory molecules in autoimmune diseases. Clin Dev Immunol 2012:269756. http://dx.doi.org/10.1155/2012/269756.
25. Riella LV, Paterson AM, Sharpe AH, Chandraker A. 2012. Role of the PD-1 pathway in the immune response. Am J Transplant 12:2575-2587. http://dx.doi.org/10.1111/j.1600-6143.2012.04224.x.
26. Zajac AJ, Blattman JN, Murali-Krishna K, Sourdive DJ, Suresh M, Altman JD, Ahmed R. 1998. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med 188:2205-2213. http://dx.doi.org/10.1084/jem.188.12.2205.
27. Barber DL, Wherry EJ, Masopust D, Zhu B, Allison JP, Sharpe AH, Freeman GJ, Ahmed R. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439:682-687. http://dx.doi.org/10.1038/nature04444.
28. Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, Reddy S, Mackey EW, Miller JD, Leslie AJ, DePierres C, Mncube Z, Duraiswamy J, Zhu B, Eichbaum Q, Altfeld M, Wherry EJ, Coovadia HM, Goulder PJ, Klenerman P, Ahmed R, Freeman GJ, Walker BD. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443:350-354. http://dx.doi.org/10.1038/nature05115.
29. Urbani S, Amadei B, Tola D, Massari M, Schivazappa S, Missale G, Ferrari C. 2006. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J Virol 80:11398-11403. http://dx.doi.org/10.1128/JVI.01177-06.
30. Radziewicz H, Ibegbu CC, Fernandez ML, Workowski KA, Obideen K, Wehbi M, Hanson HL, Steinberg JP, Masopust D, Wherry EJ, Altman JD, Rouse BT, Freeman GJ, Ahmed R, Grakoui A. 2007. Liverinfiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol 81:2545-2553. http://dx.doi.org/10.1128/JVI.02021-06.
31. Velu V, Kannanganat S, Ibegbu C, Chennareddi L, Villinger F, Freeman GJ, Ahmed R, Amara RR. 2007. Elevated expression levels of inhibitory receptor programmed death 1 on simian immunodeficiency virus-specific CD8 T cells during chronic infection but not after vaccination. J Virol 81:5819-5828. http://dx.doi.org/10.1128/JVI.00024-07.
32. Peng G, Li S, Wu W, Tan X, Chen Y, Chen Z. 2008. PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients. Mol Immunol 45:963-970. http://dx.doi.org/10.1016/j.molimm.2007.07.038.
33. Fourcade J, Sun Z, Benallaoua M, Guillaume P, Luescher IF, Sander C, Kirkwood JM, Kuchroo V, Zarour HM. 2010. Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients. J Exp Med 207:2175-2186. http://dx.doi.org/10.1084/jem.20100637.
34. Nishimura H, Nose M, Hiai H, Minato N, Honjo T. 1999. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 11:141-151. http://dx.doi.org/10.1016/S1074-7613(00)80089-8.
35. Carter LL, Leach MW, Azoitei ML, Cui J, Pelker JW, Jussif J, Benoit S, Ireland G, Luxenberg D, Askew GR, Milarski KL, Groves C, Brown T, Carito BA, Percival K, Carreno BM, Collins M, Marusic S. 2007. PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis. J Neuroimmunol 182:124-134. http://dx.doi.org/10.1016/j.jneuroim.2006.10.006.
36. Keir ME, Francisco LM, Sharpe AH. 2007. PD-1 and its ligands in T-cell immunity. Curr Opin Immunol 19:309-314. http://dx.doi.org/10.1016/j.coi.2007.04.012.
37. Nishimura H, Okazaki T, Tanaka Y, Nakatani K, Hara M, Matsumori A, Sasayama S, Mizoguchi A, Hiai H, Minato N, Honjo T. 2001. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 291:319-322. http://dx.doi.org/10.1126/science.291.5502.319.
38. Prokunina L, Castillejo-Lopez C, Oberg F, Gunnarsson I, Berg L, Magnusson V, Brookes AJ, Tentler D, Kristjansdottir H, Grondal G, Bolstad AI, Svenungsson E, Lundberg I, Sturfelt G, Jonssen A, Truedsson L, Lima G, Alcocer-Varela J, Jonsson R, Gyllensten UB, Harley JB, Alarcon-Segovia D, Steinsson K, Alarcon-Riquelme ME. 2002. A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans. Nat Genet 32:666-669. http://dx.doi.org/10.1038/ng1020.
39. Kitazawa Y, Fujino M, Wang Q, Kimura H, Azuma M, Kubo M, Abe R, Li XK. 2007. Involvement of the programmed death-1/programmed death-1 ligand pathway in CD4+CD25+regulatory T-cell activity to suppress alloimmune responses. Transplantation 83:774-782. http://dx.doi.org/10.1097/01.tp.0000256293.90270.e8.
40. Wang W, Lau R, Yu D, Zhu W, Korman A, Weber J. 2009. PD1 blockade reverses the suppression of melanoma antigen-specific CTL by CD4+ CD25(Hi) regulatory T cells. Int Immunol 21:1065-1077. http://dx.doi.org/10.1093/intimm/dxp072.
41. Yang R, Cai Z, Zhang Y, Yutzy WH, Roby KF, Roden RB. 2006. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1+CD11b+ myeloid cells. Cancer Res 66:6807-6815. http://dx.doi.org/10.1158/0008-5472.CAN-05-3755.
42. Liu Y, Zeng B, Zhang Z, Zhang Y, Yang R. 2008. B7-H1 on myeloidderived suppressor cells in immune suppression by a mouse model of ovarian cancer. Clin Immunol 129:471-481. http://dx.doi.org/10.1016/j.clim.2008.07.030.
43. Huang X, Venet F, Wang YL, Lepape A, Yuan Z, Chen Y, Swan R, Kherouf H, Monneret G, Chung CS, Ayala A. 2009. PD-1 expression by macrophages plays a pathologic role in altering microbial clearance and the innate inflammatory response to sepsis. Proc Natl Acad Sci U S A 106:6303-6308. http://dx.doi.org/10.1073/pnas.0809422106.
44. Cao D, Xu H, Guo G, Ruan Z, Fei L, Xie Z, Wu Y, Chen Y. 2013. Intrahepatic expression of programmed death-1 and its ligands in patients with HBV-related acute-on-chronic liver failure. Inflammation 36:110-120. http://dx.doi.org/10.1007/s10753-012-9525-7.
45. Zhang Y, Ma CJ, Ni L, Zhang CL, Wu XY, Kumaraguru U, Li CF, Moorman JP, Yao ZQ. 2011. Cross-talk between programmed death-1 and suppressor of cytokine signaling-1 in inhibition of IL-12 production by monocytes/macrophages in hepatitis C virus infection. J Immunol 186:3093-3103. http://dx.doi.org/10.4049/jimmunol.1002006.
46. Cho HY, Choi EK, Lee SW, Jung KO, Seo SK, Choi IW, Park SG, Choi I, Lee SW. 2009. Programmed death-1 receptor negatively regulates LPSmediated IL-12 production and differentiation of murine macrophage RAW264.7 cells. Immunol Lett 127:39-47. http://dx.doi.org/10.1016/j
47. Cho HY, Lee SW, Seo SK, Choi IW, Choi I, Lee SW. 2008. Interferonsensitive response element (ISRE) is mainly responsible for IFN-alphainduced upregulation of programmed death-1 (PD-1) in macrophages. Biochim Biophys Acta 1779:811-819. http://dx.doi.org/10.1016/j.bbagrm.2008.08.003.
48. Serezani CH, Kane S, Collins L, Morato-Marques M, Osterholzer JJ, Peters-Golden M. 2012. Macrophage dectin-1 expression is controlled by leukotriene B4 via a GM-CSF/PU.1 axis. J Immunol 189:906-915. http://dx.doi.org/10.4049/jimmunol.1200257.
49. Lasbury ME, Tang X, Durant PJ, Lee CH. 2003. Effect of transcription factor GATA-2 on phagocytic activity of alveolar macrophages from Pneumocystis carinii-infected hosts. Infect Immun 71:4943-4952. http://dx.doi.org/10.1128/IAI.71.9.4943-4952.2003.
50. Reichner JS, Fitzpatrick PA, Wakshull E, Albina JE. 2001. Receptormediated phagocytosis of rat macrophages is regulated differentially for opsonized particles and non-opsonized particles containing beta-glucan. Immunology 104:198-206. http://dx.doi.org/10.1046/j.1365-2567.2001.01291.x.
51. Roedel EQ, Cafasso DE, Lee KW, Pierce LM. 2012. Pulmonary toxicity after exposure to military-relevant heavy metal tungsten alloy particles. Toxicol Appl Pharmacol 259:74-86. http://dx.doi.org/10.1016/j.taap.2011.12.008.
52. Polancec DS, Munic Kos V, Banjanac M, Vrancic M, Cuzic S, Belamaric D, Parnham MJ, Polancec D, Erakovic Haber V. 2012. Azithromycin drives in vitro GM-CSF/IL-4-induced differentiation of human blood monocytes toward dendritic-like cells with regulatory properties. J Leukoc Biol 91:229-243. http://dx.doi.org/10.1189/jlb.1210655.
53. Hoogenkamp M, Krysinska H, Ingram R, Huang G, Barlow R, Clarke D, Ebralidze A, Zhang P, Tagoh H, Cockerill PN, Tenen DG, Bonifer C. 2007. The PU.1 locus is differentially regulated at the level of chromatin structure and noncoding transcription by alternate mechanisms at distinct developmental stages of hematopoiesis. Mol Cell Biol 27:7425-7438. http://dx.doi.org/10.1128/MCB.00905-07.
54. Wang J, Gigliotti F, Bhagwat SP, George TC, Wright TW. 2010. Immune modulation with sulfasalazine attenuates immunopathogenesis but enhances macrophage-mediated fungal clearance during Pneumocystis pneumonia. PLoS Pathog 6:e1001058. http://dx.doi.org/10.1371/journal.ppat.1001058.
55. Martin TR, Frevert CW. 2005. Innate immunity in the lungs. Proc Am Thorac Soc 2:403-411. http://dx.doi.org/10.1513/pats.200508-090JS.
56. Nakata K, Kanazawa H, Watanabe M. 2006. Why does the autoantibody against granulocyte-macrophage colony-stimulating factor cause lesions only in the lung? Respirology 11(Suppl):S65-S69. http://dx.doi.org/10.1111/j.1440-1843.2006.00812.x.
57. Patsoukis N, Brown J, Petkova V, Liu F, Li L, Boussiotis VA. 2012. Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation. Science Signal 5:ra46. http://dx.doi.org/10.1126/scisignal.2002796.
58. Zhang Y, Tuzova M, Xiao ZX, Cruikshank WW, Center DM. 2008. Pro-IL-16 recruits histone deacetylase 3 to the Skp2 core promoter through interaction with transcription factor GABP. J Immunol 180:402-408. http://dx.doi.org/10.4049/jimmunol.180.1.402.
59. Ma CJ, Ni L, Zhang Y, Zhang CL, Wu XY, Atia AN, Thayer P, Moorman JP, Yao ZQ. 2011. PD-1 negatively regulates interleukin-12 expression by limiting STAT-1 phosphorylation in monocytes/macrophages during chronic hepatitis C virus infection. Immunology 132:421-431. http://dx.doi.org/10.1111/j.1365-2567.2010.03382.x.
60. Esch KJ, Juelsgaard R, Martinez PA, Jones DE, Petersen CA. 2013. Programmed death 1-mediated T cell exhaustion during visceral leishmaniasis impairs phagocyte function. J Immunol 191:5542-5550. http://dx.doi.org/10.4049/jimmunol.1301810.
61. Trautmann L, Janbazian L, Chomont N, Said EA, Gimmig S, Bessette B, Boulassel MR, Delwart E, Sepulveda H, Balderas RS, Routy JP, Haddad EK, Sekaly RP. 2006. Upregulation of PD-1 expression on HIV-specific CD8+T cells leads to reversible immune dysfunction. Nat Med 12:1198-1202. http://dx.doi.org/10.1038/nm1482.
62. Sharpe AH, Wherry EJ, Ahmed R, Freeman GJ. 2007. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat Immunol 8:239-245. http://dx.doi.org/10.1038/ni1443.
63. Das S, Suarez G, Beswick EJ, Sierra JC, Graham DY, Reyes VE. 2006. Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection. J Immunol 176:3000-3009. http://dx.doi.org/10.4049/jimmunol.176.5.3000.
64. Smith P, Walsh CM, Mangan NE, Fallon RE, Sayers JR, McKenzie AN, Fallon PG. 2004. Schistosoma mansoni worms induce anergy of T cells via selective up-regulation of programmed death ligand 1 on macrophages. J Immunol 173:1240-1248. http://dx.doi.org/10.4049/jimmunol.173.2.1240.
65. Jurado JO, Alvarez IB, Pasquinelli V, Martinez GJ, Quiroga MF, Abbate E, Musella RM, Chuluyan HE, Garcia VE. 2008. Programmed death (PD)-1:PD-ligand 1/PD-ligand 2 pathway inhibits T cell effector functions during human tuberculosis. J Immunol 181:116-125. http://dx.doi.org/10.4049/jimmunol.181.1.116.
66. Alvarez IB, Pasquinelli V, Jurado JO, Abbate E, Musella RM, de la Barrera SS, Garcia VE. 2010. Role played by the programmed death-1-programmed death ligand pathway during innate immunity against Mycobacterium tuberculosis. J Infect Dis 202:524-532. http://dx.doi.org/10.1086/654932.
67. Velu V, Titanji K, Zhu B, Husain S, Pladevega A, Lai L, Vanderford TH, Chennareddi L, Silvestri G, Freeman GJ, Ahmed R, Amara RR. 2009. Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature 458:206-210. http://dx.doi.org/10.1038/nature07662.
68. Singh A, Mohan A, Dey AB, Mitra DK. 2013. Inhibiting the programmed death 1 pathway rescues Mycobacterium tuberculosis-specific interferon gamma-producing T cells from apoptosis in patients with pulmonary tuberculosis. J Infect Dis 208:603-615. http://dx.doi.org/10.1093/infdis/jit206.
69. Chang K, Svabek C, Vazquez-Guillamet C, Sato B, Rasche D, Wilson S, Robbins P, Ulbrandt N, Suzich J, Green J, Patera AC, Blair W, Krishnan S, Hotchkiss R. 2014. Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis. Crit Care 18:R3. http://dx.doi.org/10.1186/cc13176.
70. Topalian SL, Drake CG, Pardoll DM. 2012. Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity. Curr Opin Immunol 24:207-212. http://dx.doi.org/10.1016/j.coi.2011.12.009.
71. Seung E, Dudek TE, Allen TM, Freeman GJ, Luster AD, Tager AM. 2013. PD-1 blockade in chronically HIV-1-infected humanized mice suppresses viral loads. PLoS One 8:e77780. http://dx.doi.org/10.1371/journal.pone.0077780.
72. Telcian AG, Laza-Stanca V, Edwards MR, Harker JA, Wang H, Bartlett NW, Mallia P, Zdrenghea MT, Kebadze T, Coyle AJ, Openshaw PJ, Stanciu LA, Johnston SL. 2011. RSV-induced bronchial epithelial cell PD-L1 expression inhibits CD8+ T cell nonspecific antiviral activity. J Infect Dis 203:85-94. http://dx.doi.org/10.1093/infdis/jiq020.
73. Channappanavar R, Twardy BS, Suvas S. 2012. Blocking of PDL-1 interaction enhances primary and secondary CD8 T cell response to herpes simplex virus-1 infection. PLoS One 7:e39757. http://dx.doi.org/10.1371/journal.pone.0039757.
74. Mathieu M, Cotta-Grand N, Daudelin JF, Thebault P, Labrecque N. 2013. Notch signaling regulates PD-1 expression during CD8(+) T-cell activation. Immunol Cell Biol 91:82-88. http://dx.doi.org/10.1038/icb.2012.53.
75. Oestreich KJ, Yoon H, Ahmed R, Boss JM. 2008. NFATc1 regulates PD-1 expression upon T cell activation. J Immunol 181:4832-4839. http://dx.doi.org/10.4049/jimmunol.181.7.4832.
76. Kinter AL, Godbout EJ, McNally JP, Sereti I, Roby GA, O'Shea MA, Fauci AS. 2008. The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. J Immunol 181:6738-6746. http://dx.doi.org/10.4049/jimmunol.181.10.6738.
77. Lu P, Youngblood BA, Austin JW, Mohammed AU, Butler R, Ahmed R, Boss JM. 2014. Blimp-1 represses CD8 T cell expression of PD-1 using a feed-forward transcriptional circuit during acute viral infection. J Exp Med 211:515-527. http://dx.doi.org/10.1084/jem.20130208.
78. Kao C, Oestreich KJ, Paley MA, Crawford A, Angelosanto JM, Ali MA, Intlekofer AM, Boss JM, Reiner SL, Weinmann AS, Wherry EJ. 2011. Transcription factor T-bet represses expression of the inhibitory receptor PD-1 and sustains virus-specific CD8+ T cell responses during chronic infection. Nat Immunol 12:663-671. http://dx.doi.org/10.1038/ni.2046.
79. Yao ZQ, King E, Prayther D, Yin D, Moorman J. 2007. T cell dysfunction by hepatitisCvirus core protein involves PD-1/PDL-1 signaling. Viral Immunol 20:276-287. http://dx.doi.org/10.1089/vim.2006.0096.
80. Bowers NL, Helton ES, Huijbregts RP, Goepfert PA, Heath SL, Hel Z. 2014. Immune suppression by neutrophils in HIV-1 infection: role of PD-L1/PD-1 pathway. PLoS Pathog 10:e1003993. http://dx.doi.org/10.1371/journal.ppat.1003993.
81. Groschel S, Piggott KD, Vaglio A, Ma-Krupa W, Singh K, Goronzy JJ, Weyand CM. 2008. TLR-mediated induction of negative regulatory ligands on dendritic cells. J Mol Med 86:443-455. http://dx.doi.org/10.1007/s00109-008-0310-x.
82. Zhang C, Wang SH, Lasbury ME, Tschang D, Liao CP, Durant PJ, Lee CH. 2006. Toll-like receptor 2 mediates alveolar macrophage response to Pneumocystis murina. Infect Immun 74:1857-1864. http://dx.doi.org/10.1128/IAI.74.3.1857-1864.2006.